Spots Global Cancer Trial Database for cytomegalovirus infections
Every month we try and update this database with for cytomegalovirus infections cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Antiviral Cellular Therapy for Enhancing T-cell Reconstitution Before or After Hematopoietic Stem Cell Transplantation | NCT03475212 | Cytomegalovirus... Adenovirus Infe... EBV Infection | Virus Specific ... | - | Children's Hospital Los Angeles | |
| Study on Correlation Between Cytomegalovirus and Ocular Myasthenia Gravis | NCT05091177 | Ocular Myasthen... Cytomegalovirus... | Serum acetylcho... | 18 Years - 50 Years | First Affiliated Hospital of Jinan University | |
| Incidence and Risks Factors of CMV Reactivation in Patients Receiving of CAR-T Cells for Acute Leukemia and Lymphoma Relapse, a Cohort Study Analysis | NCT06058858 | Cytomegalovirus... Acute Leukemia B Cell Lymphoma | 1 Year - 100 Years | Assistance Publique - Hôpitaux de Paris | ||
| Administration of Rapidly Generated Multivirus-specific Cytotoxic T-Lymphocytes (VIRAGE) | NCT01070797 | Adenovirus Infe... Epstein-Barr Vi... Cytomegalovirus... Stem Cell Trans... | Multi-virus Spe... | - | Baylor College of Medicine | |
| R-MVST Cells for Treatment of Viral Infections | NCT05183490 | Epstein-Barr Vi... Cytomegalovirus... Adenovirus BK Virus Infect... | Rapidly generat... | 18 Years - | Columbia University | |
| Analysis of CMV Infections in Patients With Brain Tumors or Brain Metastases During and After Radio(Chemo)Therapy | NCT02600065 | Cytomegalovirus... | Blood draw and ... | 18 Years - | University of Erlangen-Nürnberg Medical School | |
| Incidence and Risks Factors of CMV Reactivation in Patients Receiving of CAR-T Cells for Acute Leukemia and Lymphoma Relapse, a Cohort Study Analysis | NCT06058858 | Cytomegalovirus... Acute Leukemia B Cell Lymphoma | 1 Year - 100 Years | Assistance Publique - Hôpitaux de Paris | ||
| Anti-viral T-cell Therapy by Gamma Capture | NCT06027879 | Adenovirus Cytomegalovirus... Epstein-Barr Vi... | Specific T- Lym... | 1 Month - 65 Years | University of Pittsburgh | |
| ValGanciclovir Versus ValAcyclovir for Viral Prophylaxis in Kidney Transplantation | NCT01972035 | Transplantation... Epstein-Barr Vi... Cytomegalovirus... | Valacyclovir Valganciclovir | - | University of Minnesota | |
| Study of Posoleucel (ALVR105,Viralym-M) for Multi-Virus Prevention in Patients Post-Allogeneic Hematopoietic Cell Transplant | NCT05305040 | Adenovirus Infe... BK Virus Infect... Cytomegalovirus... Epstein-Barr Vi... Human Herpes Vi... JC Virus Infect... | Posoleucel (ALV... Placebo | - | AlloVir | |
| R-MVST Cells for Treatment of Viral Infections | NCT05183490 | Epstein-Barr Vi... Cytomegalovirus... Adenovirus BK Virus Infect... | Rapidly generat... | 18 Years - | Columbia University | |
| ValGanciclovir Versus ValAcyclovir for Viral Prophylaxis in Kidney Transplantation | NCT01972035 | Transplantation... Epstein-Barr Vi... Cytomegalovirus... | Valacyclovir Valganciclovir | - | University of Minnesota | |
| Study of Posoleucel (ALVR105,Viralym-M) for Multi-Virus Prevention in Patients Post-Allogeneic Hematopoietic Cell Transplant | NCT05305040 | Adenovirus Infe... BK Virus Infect... Cytomegalovirus... Epstein-Barr Vi... Human Herpes Vi... JC Virus Infect... | Posoleucel (ALV... Placebo | - | AlloVir | |
| Posoleucel (ALVR105, Formerly Viralym-M) for Multi-Virus Prevention in Patients Post-Allogeneic Hematopoietic Cell Transplant | NCT04693637 | Adenovirus Infe... BK Virus Infect... Cytomegalovirus... Epstein-Barr Vi... Human Herpes Vi... JC Virus Infect... | Posoleucel (ALV... | 1 Year - | AlloVir | |
| Using Multi-virus Cytotoxic T-cells Following T-Cell Depleted Allogeneic HPCT for Prophylaxis Against EBV, ADV, and CMV | NCT01535885 | Epstein-Barr Vi... Adenovirus Cytomegalovirus... | Cytotoxic T Lym... | - 22 Years | Medical College of Wisconsin | |
| Cytomegalovirus (CMV) Reactivation in Allogeneic HSCT Recipient | NCT03806764 | Cytomegalovirus... Haematological ... Organ or Tissue... Immune Suppress... | Blood sampling | 18 Years - | Melbourne Health |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
